Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infection

Background Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be commonly elevated in bacterial, but not viral infection. Multiple European trials found procalcitonin-guided care reduced antibiotic use in lower r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC emergency medicine Ročník 17; číslo 1; s. 25 - 10
Hlavní autoři: Huang, David T., Angus, Derek C., Chang, Chung-Chou H., Doi, Yohei, Fine, Michael J., Kellum, John A., Peck-Palmer, Octavia M., Pike, Francis, Weissfeld, Lisa A., Yabes, Jonathan, Yealy, Donald M.
Médium: Journal Article
Jazyk:angličtina
Vydáno: London BioMed Central 29.08.2017
BioMed Central Ltd
Springer Nature B.V
BMC
Témata:
ISSN:1471-227X, 1471-227X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be commonly elevated in bacterial, but not viral infection. Multiple European trials found procalcitonin-guided care reduced antibiotic use in lower respiratory tract infection, with no apparent harm. However, applicability to US practice is limited due to trial design features impractical in the US, between-country differences, and residual safety concerns. Methods The Procalcitonin Antibiotic Consensus Trial (ProACT) is a multicenter randomized trial to determine the impact of a procalcitonin antibiotic prescribing guideline, implemented with basic reproducible strategies, in US patients with lower respiratory tract infection. Discussion We describe the trial methods using the Consolidated Standards of Reporting Trials (CONSORT) framework, and the rationale for key design decisions, including choice of eligibility criteria, choice of control arm, and approach to guideline implementation. Trial registration ClinicalTrials.gov NCT02130986 . Registered May 1, 2014.
AbstractList Background Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be commonly elevated in bacterial, but not viral infection. Multiple European trials found procalcitonin-guided care reduced antibiotic use in lower respiratory tract infection, with no apparent harm. However, applicability to US practice is limited due to trial design features impractical in the US, between-country differences, and residual safety concerns. Methods The Procalcitonin Antibiotic Consensus Trial (ProACT) is a multicenter randomized trial to determine the impact of a procalcitonin antibiotic prescribing guideline, implemented with basic reproducible strategies, in US patients with lower respiratory tract infection. Discussion We describe the trial methods using the Consolidated Standards of Reporting Trials (CONSORT) framework, and the rationale for key design decisions, including choice of eligibility criteria, choice of control arm, and approach to guideline implementation. Trial registration ClinicalTrials.gov NCT02130986 . Registered May 1, 2014.
Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be commonly elevated in bacterial, but not viral infection. Multiple European trials found procalcitonin-guided care reduced antibiotic use in lower respiratory tract infection, with no apparent harm. However, applicability to US practice is limited due to trial design features impractical in the US, between-country differences, and residual safety concerns. The Procalcitonin Antibiotic Consensus Trial (ProACT) is a multicenter randomized trial to determine the impact of a procalcitonin antibiotic prescribing guideline, implemented with basic reproducible strategies, in US patients with lower respiratory tract infection. We describe the trial methods using the Consolidated Standards of Reporting Trials (CONSORT) framework, and the rationale for key design decisions, including choice of eligibility criteria, choice of control arm, and approach to guideline implementation. ClinicalTrials.gov NCT02130986 . Registered May 1, 2014.
Abstract Background Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be commonly elevated in bacterial, but not viral infection. Multiple European trials found procalcitonin-guided care reduced antibiotic use in lower respiratory tract infection, with no apparent harm. However, applicability to US practice is limited due to trial design features impractical in the US, between-country differences, and residual safety concerns. Methods The Procalcitonin Antibiotic Consensus Trial (ProACT) is a multicenter randomized trial to determine the impact of a procalcitonin antibiotic prescribing guideline, implemented with basic reproducible strategies, in US patients with lower respiratory tract infection. Discussion We describe the trial methods using the Consolidated Standards of Reporting Trials (CONSORT) framework, and the rationale for key design decisions, including choice of eligibility criteria, choice of control arm, and approach to guideline implementation. Trial registration ClinicalTrials.gov NCT02130986 . Registered May 1, 2014.
Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be commonly elevated in bacterial, but not viral infection. Multiple European trials found procalcitonin-guided care reduced antibiotic use in lower respiratory tract infection, with no apparent harm. However, applicability to US practice is limited due to trial design features impractical in the US, between-country differences, and residual safety concerns.BACKGROUNDOveruse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be commonly elevated in bacterial, but not viral infection. Multiple European trials found procalcitonin-guided care reduced antibiotic use in lower respiratory tract infection, with no apparent harm. However, applicability to US practice is limited due to trial design features impractical in the US, between-country differences, and residual safety concerns.The Procalcitonin Antibiotic Consensus Trial (ProACT) is a multicenter randomized trial to determine the impact of a procalcitonin antibiotic prescribing guideline, implemented with basic reproducible strategies, in US patients with lower respiratory tract infection.METHODSThe Procalcitonin Antibiotic Consensus Trial (ProACT) is a multicenter randomized trial to determine the impact of a procalcitonin antibiotic prescribing guideline, implemented with basic reproducible strategies, in US patients with lower respiratory tract infection.We describe the trial methods using the Consolidated Standards of Reporting Trials (CONSORT) framework, and the rationale for key design decisions, including choice of eligibility criteria, choice of control arm, and approach to guideline implementation.DISCUSSIONWe describe the trial methods using the Consolidated Standards of Reporting Trials (CONSORT) framework, and the rationale for key design decisions, including choice of eligibility criteria, choice of control arm, and approach to guideline implementation.ClinicalTrials.gov NCT02130986 . Registered May 1, 2014.TRIAL REGISTRATIONClinicalTrials.gov NCT02130986 . Registered May 1, 2014.
Background Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be commonly elevated in bacterial, but not viral infection. Multiple European trials found procalcitonin-guided care reduced antibiotic use in lower respiratory tract infection, with no apparent harm. However, applicability to US practice is limited due to trial design features impractical in the US, between-country differences, and residual safety concerns. Methods The Procalcitonin Antibiotic Consensus Trial (ProACT) is a multicenter randomized trial to determine the impact of a procalcitonin antibiotic prescribing guideline, implemented with basic reproducible strategies, in US patients with lower respiratory tract infection. Discussion We describe the trial methods using the Consolidated Standards of Reporting Trials (CONSORT) framework, and the rationale for key design decisions, including choice of eligibility criteria, choice of control arm, and approach to guideline implementation.
ArticleNumber 25
Audience Academic
Author Fine, Michael J.
Angus, Derek C.
Pike, Francis
Yabes, Jonathan
Doi, Yohei
Chang, Chung-Chou H.
Weissfeld, Lisa A.
Huang, David T.
Kellum, John A.
Yealy, Donald M.
Peck-Palmer, Octavia M.
Author_xml – sequence: 1
  givenname: David T.
  surname: Huang
  fullname: Huang, David T.
  email: huangdt@upmc.edu
  organization: The CRISMA (Clinical Research, Investigation, and Systems Modeling of Acute Illness) Center, Department of Critical Care Medicine, University of Pittsburgh, Department of Emergency Medicine, University of Pittsburgh, The MACRO (Multidisciplinary Acute Care Research Organization) Center
– sequence: 2
  givenname: Derek C.
  surname: Angus
  fullname: Angus, Derek C.
  organization: The CRISMA (Clinical Research, Investigation, and Systems Modeling of Acute Illness) Center, Department of Critical Care Medicine, University of Pittsburgh, The MACRO (Multidisciplinary Acute Care Research Organization) Center
– sequence: 3
  givenname: Chung-Chou H.
  surname: Chang
  fullname: Chang, Chung-Chou H.
  organization: The CRISMA (Clinical Research, Investigation, and Systems Modeling of Acute Illness) Center, Division of General Internal Medicine, University of Pittsburgh
– sequence: 4
  givenname: Yohei
  surname: Doi
  fullname: Doi, Yohei
  organization: Division of Infectious Diseases, University of Pittsburgh
– sequence: 5
  givenname: Michael J.
  surname: Fine
  fullname: Fine, Michael J.
  organization: Division of General Internal Medicine, University of Pittsburgh, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System
– sequence: 6
  givenname: John A.
  surname: Kellum
  fullname: Kellum, John A.
  organization: The CRISMA (Clinical Research, Investigation, and Systems Modeling of Acute Illness) Center, Department of Critical Care Medicine, University of Pittsburgh
– sequence: 7
  givenname: Octavia M.
  surname: Peck-Palmer
  fullname: Peck-Palmer, Octavia M.
  organization: The CRISMA (Clinical Research, Investigation, and Systems Modeling of Acute Illness) Center, Department of Pathology, University of Pittsburgh
– sequence: 8
  givenname: Francis
  surname: Pike
  fullname: Pike, Francis
  organization: Eli Lilly and Company
– sequence: 9
  givenname: Lisa A.
  surname: Weissfeld
  fullname: Weissfeld, Lisa A.
  organization: Statistics Collaborative, Inc
– sequence: 10
  givenname: Jonathan
  surname: Yabes
  fullname: Yabes, Jonathan
  organization: Division of General Internal Medicine, University of Pittsburgh
– sequence: 11
  givenname: Donald M.
  surname: Yealy
  fullname: Yealy, Donald M.
  organization: Department of Emergency Medicine, University of Pittsburgh, The MACRO (Multidisciplinary Acute Care Research Organization) Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28851296$$D View this record in MEDLINE/PubMed
BookMark eNp9kt1u1DAQhSNURH_gAbhBlrgpEimZOInjm0qr5a9SJbhYJO4sx5lsXWXtxU5A5cV4PSa7Ld2tAEVRrPE5X8bjc5wcOO8wSZ5DdgZQV28i5LXgaQaCXl6n8Cg5gkJAmufi68HO-jA5jvE6I2EN8klymNd1CbmsjpJfbzHapWPatSzowXqne2S-Y8MVss_BG90bO3hnHZu5wTbWD9awuXcRXRwjWwSre3ZKytl88eo102w19iRBN2Agomv9yv7Elg0bIYHXe1B9D12OttXOIKNy739MdoxrS135cEN-bQba6tBMXT5NHne6j_js9nuSfHn_bjH_mF5--nAxn12mpsr4kEqjW5CyAzSal7zADqCVtTCgG5C8k2XeZKWptM5EIUTeNJI3tWyzqkYhMeMnycWW23p9rdbBrnS4UV5btSn4sFQ6UPc9qqZC7CQHFGVdSGi0zOqygJKoRdM0QKzzLWs9NitspxkF3e9B93ecvVJL_12Vpai4yAlwegsI_tuIcVArGw32vXbox6joRFwWUPCCpC8fSK_9GOhyN6qiyopCZPeqJd26ouH6acwTVM1KgFzUHKbfnv1FRU-LK2sokp2l-p7hxe5B_5zwLnYkEFuBCT7GgJ2iPGzSR2TbK8jUFHC1Dbii3Kop4GqaITxw3sH_58m3nkhat8SwM4t_mn4D6U8PcA
CitedBy_id crossref_primary_10_3166_afmu_2019_0182
crossref_primary_10_1373_jalm_2018_028449
crossref_primary_10_1007_s11936_019_0738_z
crossref_primary_10_1093_jalm_jfae114
crossref_primary_10_1177_0018578718762128
crossref_primary_10_1056_NEJMoa1802670
crossref_primary_10_1093_ofid_ofy327
Cites_doi 10.1001/jama.2009.1297
10.1016/S0140-6736(09)61879-1
10.7326/0003-4819-143-12-200512200-00006
10.7326/0003-4819-148-4-200802190-00008
10.1371/journal.pmed.1000111
10.1164/rccm.200512-1922OC
10.1378/chest.06-1500
10.1016/j.annemergmed.2012.02.033
10.1016/j.annemergmed.2008.01.003
10.7326/M15-1840
10.1016/S0140-6736(04)15591-8
10.1016/S0140-6736(10)60140-7
10.1086/511159
10.1016/j.annemergmed.2003.09.013
10.1371/journal.pmed.1000251
10.1093/jac/dkt301
10.1001/jamainternmed.2016.3646
10.1016/0140-6736(93)90277-N
10.1086/421997
10.1164/rccm.200406-746OC
10.1001/jama.2012.87802
10.1001/jama.294.17.2203
10.1016/j.annemergmed.2007.03.022
10.1001/jama.2012.476
10.1001/jama.2016.11764
10.1016/j.clinbiochem.2009.08.029
10.1001/jama.2016.4151
10.1001/jama.293.24.3029
10.1186/1472-6963-7-102
10.1159/000339789
10.1309/AJCP1MFYINQLECV2
10.1016/S0954-6111(98)90423-1
10.1001/jama.2010.796
10.1001/jama.2014.12923
10.1186/1471-2334-7-10
10.1056/NEJMp1408040
10.1046/j.1469-0691.2002.00406.x
10.1016/j.jaci.2007.09.029
10.1097/MLR.0b013e31819261bd
10.1016/j.annemergmed.2012.05.014
10.1093/infdis/jiv252
10.1001/jama.2009.1318
ContentType Journal Article
Contributor Prunty, Heather
Sherwin, Robert
Dachman, William
Hammel, Jean
Kurz, Michael
Filbin, Michael
Southerland, Lauren
Exline, Matthew
Lotfipour, Shahram
Hou, Peter
Fine, Jonathan
LoVecchio, Frank
Rodgers, Daniel
Wilkerson, Gentry
McCullum, David
Jovin, Franziska
Donnino, Michael
Holst, John
Rafferty, Colleen
Brown, Aaron
Suffoletto, Brian
Contributor_xml – sequence: 1
  givenname: Michael
  surname: Donnino
  fullname: Donnino, Michael
– sequence: 2
  givenname: Peter
  surname: Hou
  fullname: Hou, Peter
– sequence: 3
  givenname: Robert
  surname: Sherwin
  fullname: Sherwin, Robert
– sequence: 4
  givenname: John
  surname: Holst
  fullname: Holst, John
– sequence: 5
  givenname: Colleen
  surname: Rafferty
  fullname: Rafferty, Colleen
– sequence: 6
  givenname: Daniel
  surname: Rodgers
  fullname: Rodgers, Daniel
– sequence: 7
  givenname: William
  surname: Dachman
  fullname: Dachman, William
– sequence: 8
  givenname: Frank
  surname: LoVecchio
  fullname: LoVecchio, Frank
– sequence: 9
  givenname: Michael
  surname: Filbin
  fullname: Filbin, Michael
– sequence: 10
  givenname: Jonathan
  surname: Fine
  fullname: Fine, Jonathan
– sequence: 11
  givenname: Jean
  surname: Hammel
  fullname: Hammel, Jean
– sequence: 12
  givenname: Matthew
  surname: Exline
  fullname: Exline, Matthew
– sequence: 13
  givenname: Lauren
  surname: Southerland
  fullname: Southerland, Lauren
– sequence: 14
  givenname: Michael
  surname: Kurz
  fullname: Kurz, Michael
– sequence: 15
  givenname: David
  surname: McCullum
  fullname: McCullum, David
– sequence: 16
  givenname: Shahram
  surname: Lotfipour
  fullname: Lotfipour, Shahram
– sequence: 17
  givenname: Gentry
  surname: Wilkerson
  fullname: Wilkerson, Gentry
– sequence: 18
  givenname: Heather
  surname: Prunty
  fullname: Prunty, Heather
– sequence: 19
  givenname: Brian
  surname: Suffoletto
  fullname: Suffoletto, Brian
– sequence: 20
  givenname: Aaron
  surname: Brown
  fullname: Brown, Aaron
– sequence: 21
  givenname: Franziska
  surname: Jovin
  fullname: Jovin, Franziska
Copyright The Author(s). 2017
COPYRIGHT 2017 BioMed Central Ltd.
Copyright BioMed Central 2017
Copyright_xml – notice: The Author(s). 2017
– notice: COPYRIGHT 2017 BioMed Central Ltd.
– notice: Copyright BioMed Central 2017
CorporateAuthor on behalf of the ProACT Investigators
ProACT Investigators
CorporateAuthor_xml – name: on behalf of the ProACT Investigators
– name: ProACT Investigators
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12873-017-0138-1
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1471-227X
EndPage 10
ExternalDocumentID oai_doaj_org_article_b6eef931e758491ba908541572b4bbb1
PMC5576372
A511278312
28851296
10_1186_s12873_017_0138_1
Genre Randomized Controlled Trial
Multicenter Study
Journal Article
GeographicLocations United States
United States--US
GeographicLocations_xml – name: United States
– name: United States--US
GrantInformation_xml – fundername: National Institute of General Medical Sciences
  grantid: 1R01GM101197-01A1; 1R34GM102696-01
  funderid: http://dx.doi.org/10.13039/100000057
– fundername: ;
  grantid: 1R01GM101197-01A1; 1R34GM102696-01
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EBS
EJD
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~8M
AAYXX
AFFHD
CITATION
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AHSBF
AZQEC
DWQXO
K9.
M7N
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c603t-9cad199f1eca3534ef11d987c1ab193f952b05c6aa074772bb93b89d068e79e03
IEDL.DBID RSV
ISICitedReferencesCount 9
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000409211500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1471-227X
IngestDate Tue Oct 14 18:46:58 EDT 2025
Tue Nov 04 02:03:18 EST 2025
Fri Sep 05 11:23:47 EDT 2025
Mon Oct 06 18:29:52 EDT 2025
Tue Nov 11 10:44:03 EST 2025
Tue Nov 04 17:11:30 EST 2025
Mon Jul 21 06:04:24 EDT 2025
Sat Nov 29 03:12:52 EST 2025
Tue Nov 18 21:23:56 EST 2025
Sat Sep 06 07:28:43 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Respiratory tract infections
Biomarkers
Clinical trial
Methods (MeSH)
Anti-bacterial agents
Procalcitonin
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c603t-9cad199f1eca3534ef11d987c1ab193f952b05c6aa074772bb93b89d068e79e03
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://link.springer.com/10.1186/s12873-017-0138-1
PMID 28851296
PQID 1934604470
PQPubID 44653
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_b6eef931e758491ba908541572b4bbb1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5576372
proquest_miscellaneous_1933941434
proquest_journals_1934604470
gale_infotracmisc_A511278312
gale_infotracacademiconefile_A511278312
pubmed_primary_28851296
crossref_citationtrail_10_1186_s12873_017_0138_1
crossref_primary_10_1186_s12873_017_0138_1
springer_journals_10_1186_s12873_017_0138_1
PublicationCentury 2000
PublicationDate 2017-08-29
PublicationDateYYYYMMDD 2017-08-29
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-08-29
  day: 29
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationSubtitle BMC series – open, inclusive and trusted
PublicationTitle BMC emergency medicine
PublicationTitleAbbrev BMC Emerg Med
PublicationTitleAlternate BMC Emerg Med
PublicationYear 2017
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References S Riedel (138_CR42) 2011; 135
EJ Emanuel (138_CR23) 2012; 307
G Piaggio (138_CR36) 2012; 308
AM Harris (138_CR40) 2016; 164
M Assicot (138_CR10) 1993; 341
B Muller (138_CR9) 2001; 86
D Stolz (138_CR18) 2007; 131
LA Mandell (138_CR24) 2007; 44
L Simon (138_CR11) 2004; 39
138_CR43
PK Lindenauer (138_CR52) 2010; 303
CE Luyt (138_CR14) 2005; 171
138_CR45
138_CR44
L Dawson (138_CR56) 2009; 6
M Christ-Crain (138_CR17) 2004; 363
138_CR47
KE Fleming-Dutra (138_CR8) 2016; 315
138_CR46
VM Montori (138_CR54) 2005; 294
CY Lin (138_CR58) 2009; 47
HD Marston (138_CR4) 2016; 316
CK Cassel (138_CR55) 2012; 307
DJ Shapiro (138_CR2) 2014; 69
SR Pitts (138_CR21) 2012; 60
EA Barley (138_CR57) 1998; 92
MH Kollef (138_CR28) 2010; 375
138_CR32
138_CR31
C Nathan (138_CR3) 2014; 371
138_CR33
138_CR38
138_CR37
KF Schulz (138_CR35) 2010; 7
138_CR39
JP Metlay (138_CR5) 2007; 50
P Little (138_CR6) 2005; 293
P Schuetz (138_CR15) 2009; 302
M Meisner (138_CR41) 1997; 35
DA Talan (138_CR29) 2012; 60
P Schuetz (138_CR20) 2007; 7
B Muller (138_CR12) 2007; 7
DM Yealy (138_CR19) 2009; 302
138_CR22
138_CR25
SS Magill (138_CR1) 2014; 312
DM Yealy (138_CR49) 2005; 143
138_CR7
B Spellberg (138_CR26) 2016; 176
DM Yealy (138_CR48) 2004; 43
A Khwaja (138_CR50) 2012; 120
AR Branche (138_CR27) 2015; 212
I Boutron (138_CR34) 2008; 148
138_CR51
JT van Dissel (138_CR30) 2002; 8
L Bouadma (138_CR53) 2010; 375
138_CR13
138_CR16
References_xml – volume: 302
  start-page: 1059
  year: 2009
  ident: 138_CR15
  publication-title: JAMA
  doi: 10.1001/jama.2009.1297
– ident: 138_CR37
– volume: 375
  start-page: 463
  year: 2010
  ident: 138_CR53
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)61879-1
– volume: 143
  start-page: 881
  year: 2005
  ident: 138_CR49
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-143-12-200512200-00006
– volume: 148
  start-page: 295
  year: 2008
  ident: 138_CR34
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-148-4-200802190-00008
– volume: 6
  start-page: e1000111
  year: 2009
  ident: 138_CR56
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000111
– ident: 138_CR47
– ident: 138_CR16
  doi: 10.1164/rccm.200512-1922OC
– volume: 131
  start-page: 9
  year: 2007
  ident: 138_CR18
  publication-title: Chest
  doi: 10.1378/chest.06-1500
– volume: 60
  start-page: 536
  year: 2012
  ident: 138_CR29
  publication-title: Ann Emerg Med
  doi: 10.1016/j.annemergmed.2012.02.033
– ident: 138_CR13
  doi: 10.1016/j.annemergmed.2008.01.003
– ident: 138_CR33
– volume: 164
  start-page: 425
  year: 2016
  ident: 138_CR40
  publication-title: Ann Intern Med
  doi: 10.7326/M15-1840
– volume: 363
  start-page: 600
  year: 2004
  ident: 138_CR17
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)15591-8
– volume: 375
  start-page: 435
  year: 2010
  ident: 138_CR28
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60140-7
– volume: 44
  start-page: S27
  issue: Suppl 2
  year: 2007
  ident: 138_CR24
  publication-title: Clin Infect Dis
  doi: 10.1086/511159
– volume: 43
  start-page: 770
  year: 2004
  ident: 138_CR48
  publication-title: Ann Emerg Med
  doi: 10.1016/j.annemergmed.2003.09.013
– volume: 7
  start-page: e1000251
  year: 2010
  ident: 138_CR35
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000251
– volume: 69
  start-page: 234
  year: 2014
  ident: 138_CR2
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkt301
– ident: 138_CR46
– volume: 176
  start-page: 1254
  year: 2016
  ident: 138_CR26
  publication-title: JAMA Intern Med
  doi: 10.1001/jamainternmed.2016.3646
– ident: 138_CR22
– ident: 138_CR32
– volume: 341
  start-page: 515
  year: 1993
  ident: 138_CR10
  publication-title: Lancet
  doi: 10.1016/0140-6736(93)90277-N
– volume: 39
  start-page: 206
  year: 2004
  ident: 138_CR11
  publication-title: Clin Infect Dis
  doi: 10.1086/421997
– volume: 171
  start-page: 48
  year: 2005
  ident: 138_CR14
  publication-title: Crit Care Med
  doi: 10.1164/rccm.200406-746OC
– volume: 308
  start-page: 2594
  year: 2012
  ident: 138_CR36
  publication-title: JAMA
  doi: 10.1001/jama.2012.87802
– volume: 294
  start-page: 2203
  year: 2005
  ident: 138_CR54
  publication-title: JAMA
  doi: 10.1001/jama.294.17.2203
– volume: 50
  start-page: 221
  year: 2007
  ident: 138_CR5
  publication-title: Ann Emerg Med
  doi: 10.1016/j.annemergmed.2007.03.022
– volume: 307
  start-page: 1801
  year: 2012
  ident: 138_CR55
  publication-title: JAMA
  doi: 10.1001/jama.2012.476
– volume: 316
  start-page: 1193
  year: 2016
  ident: 138_CR4
  publication-title: JAMA
  doi: 10.1001/jama.2016.11764
– ident: 138_CR45
– ident: 138_CR25
– ident: 138_CR43
  doi: 10.1016/j.clinbiochem.2009.08.029
– ident: 138_CR51
  doi: 10.1016/j.annemergmed.2008.01.003
– volume: 315
  start-page: 1864
  year: 2016
  ident: 138_CR8
  publication-title: JAMA
  doi: 10.1001/jama.2016.4151
– ident: 138_CR31
– volume: 293
  start-page: 3029
  year: 2005
  ident: 138_CR6
  publication-title: JAMA
  doi: 10.1001/jama.293.24.3029
– volume: 307
  start-page: 367
  year: 2012
  ident: 138_CR23
  publication-title: JAMA
– volume: 7
  start-page: 102
  year: 2007
  ident: 138_CR20
  publication-title: BMC Health Serv Res
  doi: 10.1186/1472-6963-7-102
– ident: 138_CR39
– volume: 120
  start-page: c179
  year: 2012
  ident: 138_CR50
  publication-title: Nephron Clin Pract
  doi: 10.1159/000339789
– volume: 35
  start-page: 597
  year: 1997
  ident: 138_CR41
  publication-title: Eur J Clin Chem Clin Biochem
– volume: 135
  start-page: 182
  year: 2011
  ident: 138_CR42
  publication-title: Am J Clin Pathol
  doi: 10.1309/AJCP1MFYINQLECV2
– volume: 92
  start-page: 1207
  year: 1998
  ident: 138_CR57
  publication-title: Respir Med
  doi: 10.1016/S0954-6111(98)90423-1
– ident: 138_CR44
– volume: 303
  start-page: 2359
  year: 2010
  ident: 138_CR52
  publication-title: JAMA
  doi: 10.1001/jama.2010.796
– volume: 312
  start-page: 1438
  year: 2014
  ident: 138_CR1
  publication-title: JAMA
  doi: 10.1001/jama.2014.12923
– volume: 7
  start-page: 10
  year: 2007
  ident: 138_CR12
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-7-10
– volume: 371
  start-page: 1761
  year: 2014
  ident: 138_CR3
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp1408040
– ident: 138_CR7
– volume: 8
  start-page: 70
  year: 2002
  ident: 138_CR30
  publication-title: Clin Microbiol Infect
  doi: 10.1046/j.1469-0691.2002.00406.x
– ident: 138_CR38
  doi: 10.1016/j.jaci.2007.09.029
– volume: 86
  start-page: 396
  year: 2001
  ident: 138_CR9
  publication-title: J Clin Endocrinol Metab
– volume: 47
  start-page: 524
  year: 2009
  ident: 138_CR58
  publication-title: Med Care
  doi: 10.1097/MLR.0b013e31819261bd
– volume: 60
  start-page: 679
  year: 2012
  ident: 138_CR21
  publication-title: Ann Emerg Med
  doi: 10.1016/j.annemergmed.2012.05.014
– volume: 212
  start-page: 1692
  year: 2015
  ident: 138_CR27
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiv252
– volume: 302
  start-page: 1115
  year: 2009
  ident: 138_CR19
  publication-title: JAMA
  doi: 10.1001/jama.2009.1318
SSID ssj0017819
Score 2.1304173
Snippet Background Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be...
Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be commonly elevated...
Background Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to be...
Abstract Background Overuse of antibiotics is a major public health problem, contributing to growing antibiotic resistance. Procalcitonin has been reported to...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 25
SubjectTerms Anti-bacterial agents
Anti-Bacterial Agents - therapeutic use
Antibiotic resistance
Antibiotics
Asthma
Bacterial infections
Biomarkers
Biomarkers - blood
Calcitonin - blood
Calcitonin Gene-Related Peptide
Chronic obstructive pulmonary disease
Clinical decision making
Clinical medicine
Clinical trial
Clinical trials
Decision Making
Drug resistance in microorganisms
Drug therapy
Emergency medical care
Emergency Medicine
Emergency Service, Hospital
Enrollments
Evidence-based medicine
Female
General emergency medicine
Health aspects
Hospitalization
Humans
Infections
Male
Medicine
Medicine & Public Health
Methods
Methods (MeSH)
Outcome and Process Assessment, Health Care
Patients
Physicians
Pneumonia
Practice Guidelines as Topic
Procalcitonin
Protein Precursors - blood
Public health
Research Design
Respiratory tract diseases
Respiratory tract infection
Respiratory tract infections
Respiratory Tract Infections - drug therapy
Risk factors
Study Protocol
Treatment Outcome
United States
Ventilators
Viral infections
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQCiEuiDeBBRkJiWe0cZz4cSwLKy6sOBRpb5ZfgUrFXfXBgT_G32PGSbvNIuDCNR67tufz-HM9niHkmY-sBh4aStn5pmxCqErldCiRPOigrBKuTzYhT0_V2Zn-tJfqC33C-vDA_cQdORFjpzmLQGwbzZzVQBJg15G1a5xz-eBTSb09TA33BxI2uuEOkylxtAIrLNFvCN0sYYWz0S6Ug_X_bpL39qTL_pKXLk3zXnRyk9wYSCSd9J2_Ra7EdJtc-zhck98hP99lvwxqU6DL4d--SBcdBbZH8WmAnXtYyWmW6CTho5EFNEQxdycmvljRKaKSvgDJyfH05RtqafY7xI7FJbSYwuLb7EcMNOf8wIbPR43ai0a_bGYBgUXh8xwzstHlxeU-1Ld-TbcOYeku-Xzyfnr8oRwyNJReVHxdam8D07pj0Vve8iZ2jAWtpGfWATPsdFu7qvXCWozTDypzmjulQyVUlDpW_B45SIsUHxBa8QC_BRZCBNZ0irtWymhbwFhgPgpVkGqrMeOH8OWYRWNu8jFGCdMr2YCSDSrZsIK82lU572N3_E34LcJgJ4hht_MHAKMZwGj-BcaCPEcQGTQOOIN2eOMAQ8QwW2aC9FYqzuqCHI4kYVH7cfEWhmYwKisDM9qIqmlkVZCnu2KsiY5yKS42WYbrBkhwU5D7PWp3Q6qVQnonCiJHeB6NeVySZl9zyPEWjqVcQrdeb5G_160_TenD_zGlj8j1Oq9bfCx0SA7Wy018TK767-vZavkkr_pfL_9dHw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZgQQgJ8VhegQUZCYlntHGSxvYJlYUVF1YcitSb5VeWSiUpacuBP8bfY8Zx280i9sI1tice6_PnsT2eIeS59SwHO9SlvLZlWjqXpcJIl6LxIJ3QojJ9sgl-ciKmU_klHrgto1vlhhMDUbvW4hn5IRgaZZWVJc_eLX6kmDUKb1djCo3L5AqmzUac8-l2w8U4LHfxJpOJ6nAJXMzRewidLWGes8FaFEL2_03MZ1am816T565Ow4p0fOt_dblNbkZblI578Nwhl3yzT659jrft--RGf6ZH-6dKd8nvD8Hdg-rG0S4eInra1hSMSIovDvTcAkE0s4aOG3yL0oJgiilBMZ_Gkk4Q7PQl1BwfTV69pZoGd0bU1HcgsXHt99kv72hIJYKCFwOheif0dD1ziFcKn-eY6I12O58BaK_tim78zJp75Ovxx8nRpzQmfkhtlRWrVFrtmJQ181YXo6L0NWNOCm6ZNjB2tRzlJhvZSmsM_89zY2RhhHRZJTyXPivuk72mbfxDQrPCwb-AeCrHyloUZsS51yOArmPWVyIh2QYCysao6JicY67C7khUqkeNAtQoRI1iCXm9bbLoQ4JcVPk94mpbEaN5hw9td6oiOShTeV_LgnnYvJWSGS3BEAbLCjQrjTEg5AWiUiHn4Ajq-HQCVMToXWqMVjMXBcsTcjCoCVxhh8UbQKrIVUu1Q2NCnm2LsSX63zW-XYc6hSzBti4T8qCfBluVciHQaqwSwgcTZKDzsKSZfQuRzEew2y04dOvNZiqd6da_hvTRxUo8JtfzMMXxddEB2Vt1a_-EXLU_V7Nl9zQQxB9trXBH
  priority: 102
  providerName: ProQuest
Title Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infection
URI https://link.springer.com/article/10.1186/s12873-017-0138-1
https://www.ncbi.nlm.nih.gov/pubmed/28851296
https://www.proquest.com/docview/1934604470
https://www.proquest.com/docview/1933941434
https://pubmed.ncbi.nlm.nih.gov/PMC5576372
https://doaj.org/article/b6eef931e758491ba908541572b4bbb1
Volume 17
WOSCitedRecordID wos000409211500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: Open Access: BioMedCentral Open Access Titles
  customDbUrl:
  eissn: 1471-227X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017819
  issn: 1471-227X
  databaseCode: RBZ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1471-227X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017819
  issn: 1471-227X
  databaseCode: DOA
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1471-227X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017819
  issn: 1471-227X
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1471-227X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017819
  issn: 1471-227X
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1471-227X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017819
  issn: 1471-227X
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1471-227X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017819
  issn: 1471-227X
  databaseCode: PIMPY
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: Springer Nature - Connect here FIRST to enable access
  customDbUrl:
  eissn: 1471-227X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017819
  issn: 1471-227X
  databaseCode: RSV
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3ZbtQw0IIWIV64j0BZGQmJo0TEuWw_bksreOhqBQsqT5avlJWWbJXd5YEf4_eY8SbbphwSvERKPJ5k7JnxTDyeIeSp9SwFO9TFvLJ5nDuXxMJIF6PxIJ3QojTrYhN8NBLHx3LcnuNedNHu3ZZk0NRBrEX5egGalGPsD4ZKgpSCy7NdYLIZdNE_fNpsHXBY49rty9926y1AIU__r9r43HJ0MVTywn5pWIYOb_wXATfJ9dbqpMM1m9wil3x9m1w9avfV75Afb0IgB9W1o037e9DTeUXBPKR4lkDPLIh-Pa3psMZTJnNARLHYJ1bKWNAJsjF9DpDD_cmLV1TTEKiI5PgGMNZu_nX63TsaioQg4tMeUn2G9GQ1dciJFB7PsIQbbc6iAaC_tkvaRZDVd8nHw4PJ_tu4LekQ2zLJlrG02jEpK-atzoos9xVjTgpumTZgSlaySE1S2FJrTOzPU2NkZoR0SSk8lz7J7pGtel77B4QmmYN3gUopHcsrkZmCc68LYErHrC9FRJJunpVt851j2Y2ZCn6PKNV6QhRMiMIJUSwiLzddTtfJPv4GvIfMswHEPN3hwbw5Ua3YK1N6X8mMeXDLcsmMlmDigs0ElOXGGEDyDFlPoTbBEdTtoQggEfNyqSHaw1xkLI3ITg8StIDtN3fMq1ottFAwonmZ5DlPIvJk04w9MbKu9vNVgMlkDlZzHpH7a17fkJQKgfZgGRHek4Iezf2Wevol5CgvwI_NOHzWbicL5z7rT0P68J-gH5FraRAmPEa0Q7aWzco_Jlfst-V00QzIZX7Mw1UMyPbewWj8fhB-uMDd-N3R-PMgqI2fd_Vm_Q
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9QwELZKiwAJcZQrUMBIoHJFjZNsYj8gtLRUrdpd7cMilSfjK2Wlkix7gOBH8crfYybHtimib33gNbYnsTPzecaeg5CnxrEQ9FDrp5mJ_djawOdaWB-VB2G54omuik2k_T4_OBCDJfKriYVBt8oGE0ugtoXBM_INUDTiJIjjNHg7_upj1Si8XW1KaFRssed-fAeTbfpmdwv-77Mw3H4_3Nzx66oCvkmCaOYLoywTImPOqKgTxS5jzILlbZjS8JJMdEIddEyiFOaWT0OtRaS5sEHCXSpcEAHdC2QlBmYPlsnKYLc3-Li4t0hhg63vThlPNqaA_in6K6F7JyALa-1-ZZGAv7eCE3vhaT_NU5e15R64ff1_W70b5FqtbdNuJR43yZLLV8mlXu1PsEquVqeWtArGukV-b5UOLVTllk7qY1JHi4yCmkwxpkIdGYDAfJTTbo7RNgUQplj0FCuGTOkQxZk-h57dzeGL11TR0mETV9ZNgGJuiy-jn87SslgKEh63iKpjoofzkUWJpPD4CEvZ0cmxVwSMV2ZGG0-6_Db5cC7LeIcs50Xu7hEaRBbeBdCaWBZnPNKdNHWqA8JpmXEJ90jQsJw0dd53LD9yJEv7jyey4lIJXCqRSyXzyMvFkHGV9OSszu-QjxcdMV95-aCYHMoa_qROnMtExByYp7FgWglQ9UF3hJnFWmsgso5SIBFVcQVVHRwCU8T8ZLKLdkHKIxZ6ZK3VE9DQtJsbAZA1Gk_lMfd75MmiGUeih2HuinnZJxIxWA-xR-5WYreYUsg56sWJR9KWQLbm3G7JR5_LXO0dsOejFD7rVSO6Jz7rX0t6_-xJPCaXd4a9fbm_2997QK6EJbxgLNUaWZ5N5u4huWi-zUbTyaManij5dN4y_QdzIM6P
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3ZbtQw0EIFVbxwH4ECRkLijBonTmw_Li0rELCqoKC-Wb5SVlqyq-wuD_wYv8dMjm1TDgnxGo8nGXs8nslchDxygaWgh_pYlI7H3Pskllb5GJUH5aWRhW2bTYjJRB4dqYOuz-myj3bvXZJtTgNWaapWuwtftkdcFrtLkKoC44AwbBJOLJg_5zkYMhjT9eHj540bQcB917kyfzttcBk1Nft_lcynrqazYZNnfKfNlTS-_N_EXCGXOm2Ujlr2uUrOheoa2X7f-duvkx_7TYAHNZWndffbMNB5SUFtpJhjYGYOREI1reiowuyTOSCi2AQUO2gs6SGyN30CkKO9w6cvqKFNACOSFmrAWPn51-n34GnTPAQRLwZIzQnS4_XUI4dSeDzD1m60PokSgPnGrWgfWVbdIJ_Grw73Xsddq4fYFUm2ipUznilVsuBMlmc8lIx5JYVjxoKKWao8tUnuCmOw4L9IrVWZlconhQxChSS7SbaqeRVuE5pkHt4FoqbwjJcys7kQweTArJ65UMiIJP2ea9fVQcd2HDPd2EOy0O2GaNgQjRuiWUSebaYs2iIgfwN-iYy0AcT63c2DeX2sO3GgbRFCqTIWwFzjilmjQPUFXQoo49ZaQPIY2VCjlMEVNF2yBJCI9br0CPVkITOWRmRnAAnSwQ2He0bWnXRaalhRXiSciyQiDzfDOBMj7qowXzcwmeKgTfOI3Gr5fkNSKiXqiUVExOBEDGgejlTTL03t8hzs20zAZz3vz8Wpz_rTkt75J-gHZPtgf6zfvZm8vUsups25wkyjHbK1qtfhHrngvq2my_p-Iyt-AkkMbLU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design+and+rationale+of+the+Procalcitonin+Antibiotic+Consensus+Trial+%28ProACT%29%2C+a+multicenter+randomized+trial+of+procalcitonin+antibiotic+guidance+in+lower+respiratory+tract+infection&rft.jtitle=BMC+emergency+medicine&rft.au=Huang%2C+David+T.&rft.au=Angus%2C+Derek+C.&rft.au=Chang%2C+Chung-Chou+H.&rft.au=Doi%2C+Yohei&rft.date=2017-08-29&rft.pub=BioMed+Central&rft.eissn=1471-227X&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs12873-017-0138-1&rft.externalDocID=10_1186_s12873_017_0138_1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-227X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-227X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-227X&client=summon